Clinical Trials Insight: 700051686

Trial Profile

Clinical Trials Insight: 700051686

Phase of Trial: Phase II

Latest Information Update: 14 Dec 2009

At a glance

  • Drugs Elotuzumab (Primary)
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Sponsors Abbott Biotherapeutics Corp; Bristol-Myers Squibb
  • Most Recent Events

    • 14 Dec 2009 New trial record.
    • 07 Dec 2009 The anticipated trial initiation date is in the first half of 2010, according to a Bristol-Myers Squibb media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top